Trial Profile
Pilot study: Imatinib for the treatment of plexiform neurofibromas in NF1 patients. [Studio pilota sul trattamento con Imatinib di neurofibromi plessiformi in pazienti con neurofibromatosi di tipo I]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2014
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Neurofibromatosis 1; Plexiform neurofibroma
- Focus Biomarker; Therapeutic Use
- 10 Mar 2014 New trial record